![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Deal date
KANDO id: 695019
Financial Transaction:
Series A
BioRelix Inc
Currency
United States Dollar
Value in original currency
25,750,000
Value in USD
25,750,000
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
CHL Medical PartnersVenture capital firm focused on early-stage healthcare sectors. |
United States | Follow-on investment. Deal professionals: Ronald W Lennox |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Aisling Capital |
United States | Initial investment. |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Alexandria Real Estate Equities Inc |
United States | Follow-on investment. |
|
|
Elm Street Ventures |
United States | Follow-on investment. |
|
New Leaf Venture Partners(NLV) |
United States | Initial investment. |
|
Novartis Venture FundsThe corporate venturing arm of Novartis. |
Switzerland | Follow-on investment. |